The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Abstract
Recent evidence indicates that the nucleus basalis of Meynert, a distinct population of basal forebrain neurons, is a major source of cholinergic innervation of the cerebral cortex. Postmortem studies have previously demonstrated profound reduction in the presynaptic markers for cholinergic neurons in the cortex of patients with Alzheimer's disease and senile dementia of the Alzheimer's type. The results of this study show that neurons of the nucleus basalis of Meynert undergo a profound (greater than 75 percent) and selective degeneration in these patients and provide a pathological substrate of the cholinergic deficiency in their brains. Demonstration of selective degeneration of such neurons represents the first documentation of a loss of a transmitter-specific neuronal population in a major disorder of higher cortical function and, as such, points to a critical subcortical lesion in Alzheimer's patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, they mediate the effects of arousal in cortical circuits92 under the effects of acetylcholine, which is also highly disrupted early in AD through the loss of cholinergic neurons in the basal forebrain93.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [93]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Self-citationAsher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Krettek, J. E., & Price, J. L. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901780204 · Cited by 1,293
The connections of the septal region in the rat
Swanson, L. W., & Cowan, W. M. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901860408 · Cited by 1,136
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
Shute, C. C. D., & Lewis, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,120
HIPPOCAMPAL PROJECTIONS AND RELATED NEURAL PATHWAYS TO THE MID-BRAIN IN THE CAT
Nauta, W. J. H. (1958) · Brain · doi:10.1093/brain/81.3.319 · Cited by 990
Some morphometric aspects of the brain in senile dementia of the alzheimer type
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801
Activity of pallidal neurons during movement.
DeLong, M. R. (1971) · Journal of Neurophysiology · doi:10.1152/jn.1971.34.3.414 · Cited by 734
Self-citationNeurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724
Flagged first, then by citations
Research works printed but not linked: 10
- Brody, H., Alzheimer's Disease: Senile Dementia and Related Disorders 7: 345 (1978).
- Coyle, J. T., Brain Neurotransmitters and Receptors in Aging and Age-Related Disorders: 149 (1981).
- DAVIS, K.L., BRAIN ACETYLCHOLINE: 205 (1979).
- DRACHMAN, D.A., AGING 7: 141 (1978).
- HASSLER, R, BEHAV AGING NERVOUS: 284 (1965).
- KUHAR, M.J., BIOL CHOLINERGIC FUN: 3 (1976).
- PARENT, A, ADVANCES IN NEUROLOGY 24: 1 (1979).
- TOMLINSON, B.E., DEMENTIA: 113 (1977).
- WANG, H, AGING DEMENTIA: 1 (1977).
- WANG, H.S., REPORT PANEL INFLAMM: 61 (1979).
Cited by
Sorted by citations
Items 501–600 of 1,021
Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk, G. L. (2006) · PubMed · Cited by 134
The amyloid pathology progresses in a neurotransmitter-specific manner
Bell, K. F. S., Ducatenzeiler, A., Ribeiro‐da‐Silva, A., Duff, K., Bennett, D. A., & Cuello, A. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.034 · Cited by 139
Prefrontal cortical projections to the cholinergic neurons in the basal forebrain
Gaykema, R. P. A., Weeghel, R. V., Hersh, L. B., & Luiten, P. G. M. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903030405 · Cited by 134
Sunderland, T., Tariot, P. N., & NEWHOUSE, P. A. (1988) · Brain Research · doi:10.1016/0006-8993(88)91227-9 · Cited by 134
Kehoe, P. G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171119 · Cited by 133
Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome
Contestabile, A., Benfenati, F., & Gasparini, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.003 · Cited by 134
Ginsberg, S. D., Mufson, E. J., Alldred, M. J., Counts, S., Wuu, J., Nixon, R. A., & Che, S. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.05.012 · Cited by 132
Foley, A., Murphy, K. J., Hirst, W. D., Gallagher, H. C., Hagan, J. J., Upton, N., Walsh, F. S., & Regan, C. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300332 · Cited by 133
Parnetti, L., Amenta, F., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00312-8 · Cited by 132
Basal Forebrain Cholinergic Modulation of Sleep Transitions
Irmak, S. O., & de Lecea, L. (2014) · SLEEP · doi:10.5665/sleep.4246 · Cited by 138
Personality Alterations in Dementia of the Alzheimer Type
Petry, S. D., Cummings, J. L., Hill, M. A., & Shapira, J. S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520350025009 · Cited by 131
CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS
Price, D. L., & Sisodia, S. S. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.435 · Cited by 132
Self-citationThe deterioration of semantic memory in Alzheimer's disease.
Salmon, D. P., Butters, N., & Chan, A. S.-Y. (1999) · Canadian Journal of Experimental Psychology/Revue canadienne de psychologie expérimentale · doi:10.1037/h0087303 · Cited by 140
Saper, C. B., & Chelimsky, T. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90286-0 · Cited by 131
Wang, R., Zhang, H., & Tang, X. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01030-5 · Cited by 131
Scopolamine amnesia of passive avoidance: A deficit of information acquisition
Rush, D. K. (1988) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(88)90938-7 · Cited by 131
Neurotransmitters in the cerebral cortex
Jones, E. G. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.65.2.0135 · Cited by 131
Cuello, A. C., Stephens, P. H., Tagari, P. C., et al. (1986) · Brain Research · doi:10.1016/0006-8993(86)90202-7 · Cited by 131
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases
Kampmann, M. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00806-0 · Cited by 142
Naoi, M., Maruyama, W., Dostert, P., et al. (1996) · Brain Research · doi:10.1016/0006-8993(95)01325-3 · Cited by 130
Neuronal responses related to reinforcement in the primate basal forebrain
Wilson, F. A. W., & Rolls, E. T. (1990) · Brain Research · doi:10.1016/0006-8993(90)90546-n · Cited by 130
Ávila, J., Wandosell, F. G., & Hernández, F. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.40 · Cited by 139
Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons
O’Meara, G. F., Coumis, U., Ma, S. Y., Kehr, J., Mahoney, S., Bacon, A., Allen, S. J., Holmes, F. E., Kahl, U., Wang, F. H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210254597 · Cited by 130
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease
Palmer, A. M., Francis, P. T., Bowen, D. M., Benton, J. S., Neary, D., Mann, D. M. A., & Snowden, J. S. (1987) · Brain Research · doi:10.1016/0006-8993(87)90018-7 · Cited by 130
Scopolamine-disruption of radial arm maze performance: modification by noradrenergic depletion
Decker, M. W., & Gallagher, M. (1987) · Brain Research · doi:10.1016/0006-8993(87)90179-x · Cited by 130
Goedert, M., Fine, A., Dawbarn, D., Wilcock, G. K., & Chao, M. V. (1989) · Molecular Brain Research · doi:10.1016/0169-328x(89)90011-9 · Cited by 130
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 136
Cholinergic activity and amyloid precursor protein metabolism
Roberson, M. R. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00016-7 · Cited by 127
Acetylcholinesterase-Aβ Complexes Are More Toxic than Aβ Fibrils in Rat Hippocampus
Reyes, A. E., Chacón, M. A., Dinamarca, M. C., Cerpa, W. F., Morgan, C., & Inestrosa, N. C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63774-1 · Cited by 129
Tagliavini, F., & Pilleri, G. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90203-4 · Cited by 128
Estrogen and Nerve Growth Factor‐related Systems in Brain
Gibbs, R. B. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb55792.x · Cited by 129
Sundström, E., Archer, T., Melander, T., & Hökfelt, T. G. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90233-9 · Cited by 127
Familial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway
Lippa, C. F., Saunders, A. M., Smith, T. W., Swearer, J. M., Drachman, D. A., Ghetti, B., Nee, L., Pulaski-Salo, D., Dickson, D., Robitaille, Y., et al. (1996) · Neurology · doi:10.1212/wnl.46.2.406 · Cited by 97
Ingham, C. A., Bolam, J. P., Wainer, B. H., & Smith, A. D. (1985) · The Journal of Comparative Neurology · doi:10.1002/cne.902390205 · Cited by 127
Chui, H. C. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520430102025 · Cited by 127
Deep Brain Stimulation for the Treatment of Alzheimer Disease and Dementias
Laxton, A. W., & Lozano, A. M. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2012.06.028 · Cited by 126
Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?
Fahnestock, M. L., Garzón, D. V., Holsinger, R. M. D., & Michalski, B. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_22 · Cited by 125
Age-related loss of nerve growth factor sensitivity in rat basal forebrain neurons
Koh, S., & Loy, R. (1988) · Brain Research · doi:10.1016/0006-8993(88)91015-3 · Cited by 127
Retrograde cell degeneration in the basal nucleus in monkey and man
Pearson, R. C. A., Gatter, K. C., & Powell, T. P. S. (1983) · Brain Research · doi:10.1016/0006-8993(83)90637-6 · Cited by 126
Epigenomics of Alzheimer's disease
Bennett, D. A., Yu, L., Yang, J., Srivastava, G. P., Aubin, C., & Jager, P. L. D. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.006 · Cited by 126
A Dendritic Substrate for the Cholinergic Control of Neocortical Output Neurons
Williams, S. R., & Fletcher, L. N. (2018) · Neuron · doi:10.1016/j.neuron.2018.11.035 · Cited by 128
Cortical distribution of gangliosides in Alzheimer's disease
Kraĉun, I., Bognar, S. K., Talan-Hranilović, J., & Ćosović, Č. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90058-y · Cited by 125
The Choline Transporter Resurfaces: New Roles for Synaptic Vesicles?
Ferguson, S. M. (2004) · Molecular Interventions · doi:10.1124/mi.4.1.22 · Cited by 129
Serotonin and acetylcholine release response in the rat hippocampus during a spatial memory task
Stancampiano, R., Cocco, S., Cugusi, C., Sarais, L., & Fadda, F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00397-2 · Cited by 126
Growth-factor gene therapy for neurodegenerative disorders
Tuszynski, M. H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00006-6 · Cited by 125
Ingham, C. A., Bolam, J. P., & Smith, A. D. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902730210 · Cited by 124
Nardone, R., Tezzon, F., Höller, Y., Golaszewski, S., Trinka, E., & Brigo, F. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12223 · Cited by 118
Glial scars are permeable to the neurotoxic environment of chronic stroke infarcts
Zbesko, J. C., Nguyen, T. V., Yang, T., Frye, J. B., Hussain, O. M., Hayes, M. I., Chung, A. G., Day, W. A., Stepanovic, K., Krumberger, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.007 · Cited by 128
Pharmacological Profile of Huperzine A, a Novel Acetylcholinesterase Inhibitor from Chinese Herb
Tang, X. C., & Han, Y. (1999) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1999.tb00105.x · Cited by 124
Morris, A. W. J., Carare, R. O., Schreiber, S., & Hawkes, C. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00251 · Cited by 131
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model
Lockrow, J. P., Prakasam, A., Huang, P., Bimonte‐Nelson, H. A., Sambamurti, K., & Granholm, A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.021 · Cited by 126
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease
Cutler, N. R., Polinsky, R. J., Srarnek, J. J., Enz, A., Jhee, S. S., Mancione, L., Hourani, J., & Zolnouni, P. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00645.x · Cited by 123
Casamenti, F., Prosperi, C., Scali, C., Giovannelli, L., Colivicchi, M. A., Faussone‐Pellegrini, M. S., & Pepeu, G. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00680-0 · Cited by 122
The bed nucleus‐amygdala continuum in human and monkey
Price, D. L., Martin, L. J., Powers, R. E., & Dellovade, T. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903090404 · Cited by 123
Self-citationA comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.
Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1984) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.2.201 · Cited by 123
Majdi, A., Sadigh‐Eteghad, S., Aghsan, S. R., Farajdokht, F., Vatandoust, S. M., Abbas-Abad, A. N., & Mahmoudi, J. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0089 · Cited by 130
Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses
Lippa, C. F., Hamos, J. E., Pulaski-Salo, D., DeGennaro, L. J., & Drachman, D. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90115-e · Cited by 123
Pharmacological Treatment of Alzheimer Disease
Massoud, F., & Léger, G. C. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601003 · Cited by 130
Cholinergic system function and cognition in mild cognitive impairment
Haense, C., Kalbe, E., Herholz, K., Hohmann, C., Neumaier, B., Krais, R., & Heiss, W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.015 · Cited by 127
Rahim, F., Ullah, H., Taha, M., Wadood, A., Javed, M. T., Rehman, W. U., Nawaz, M., Ashraf, M., Ali, M., Sajid, M., et al. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.07.005 · Cited by 121
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
Wong, K. Y., Roy, J., Fung, M., Heng, B. C., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1125 · Cited by 122
Current therapeutic targets for the treatment of Alzheimer’s disease
Grill, J. D., & Cummings, J. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 123
Giovanni, S. D., Borloz, A., Urbain, A., Marston, A., Hostettmann, K., Carrupt, P., & Reist, M. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.10.004 · Cited by 121
The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease
Tiraboschi, P., Hansen, L. A., Alford, M. F., Masliah, E., Thal, L. J., & Corey‐Bloom, J. (2000) · Neurology · doi:10.1212/wnl.55.9.1278 · Cited by 122
Basal forebrain infarction. A clinicopathologic correlation.
Phillips, S., Sangalang, V., & Sterns, G. L. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520230024008 · Cited by 121
Lindefors, N., Ernfors, P., Falkenberg, T., & Persson, H. (1992) · Experimental Brain Research · doi:10.1007/bf02259130 · Cited by 124
Neural Transplantation in Animal Models of Dementia
Dunnett, S. B. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00448.x · Cited by 119
The dendritic hypothesis for Alzheimer's disease pathophysiology
Cochran, J. N., Hall, A. M., & Roberson, E. D. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.004 · Cited by 114
Neural and cognitive plasticity: From maps to minds.
Mercado, E. (2008) · Psychological Bulletin · doi:10.1037/0033-2909.134.1.109 · Cited by 128
Velázquez, R., Ash, J. A., Powers, B. E., Kelley, C. M., Strawderman, M. S., Luscher, Z. I., Ginsberg, S. D., Mufson, E. J., & Strupp, B. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.04.016 · Cited by 124
Wilson, F., & Rolls, E. T. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-04-01254.1990 · Cited by 120
Mizukawa, K., McGeer, P. L., Tago, H., Peng, J. H., McGeer, E. G., & Kimura, H. (1986) · Brain Research · doi:10.1016/0006-8993(86)90253-2 · Cited by 120
Semick, S. A., Bharadwaj, R. A., Collado‐Torres, L., Tao, R., Shin, J. H., Deep‐Soboslay, A., Weiss, J. R., Weinberger, D. R., Hyde, T. M., Kleinman, J. E., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01966-5 · Cited by 121
Adeno-Associated Viral Vectors in Neuroscience Research
Haggerty, D. L., Grecco, G. G., Reeves, K. C., & Atwood, B. K. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.012 · Cited by 135
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Rahman, M. A., Islam, K., Rahman, S., & Alamin, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02177-w · Cited by 121
Ruberg, M., Rieger, F., Villageois, A. P., Bonnet, A. M., & Agid, Y. (1986) · Brain Research · doi:10.1016/0006-8993(86)91401-0 · Cited by 119
Cholinergic Involvement in Alzheimer’s Disease. A Link with NGF Maturation and Degradation
Cuello, A. C., Bruno, M. A., Allard, S., León, W., & Iulita, M. F. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9238-z · Cited by 119
Irie, T., Fukushi, K., Akimoto, Y., et al. (1994) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)90159-7 · Cited by 119
Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia
Arai, H., Emson, P. C., Mountjoy, C. Q., Carassco, L. H., & Heizmann, C. W. (1987) · Brain Research · doi:10.1016/0006-8993(87)90974-7 · Cited by 118
Castle, M. J., Baltanás, F. C., Kovács, I., Nagahara, A. H., Barba, D., & Tuszynski, M. H. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.367 · Cited by 117
Alreja, M., Wu, M., Liu, W., Atkins, J. B., Léránth, C., & Shanabrough, M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08103.2000 · Cited by 118
Brain aging and Alzheimer's disease; use it or lose it
Swaab, D. F., Dubelaar, E. J. G., Hofman, M. A., Scherder, E., Someren, E. J. W. V., & Verwer, R. W. H. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)38086-5 · Cited by 119
German, D. C., Quintero, E. M., Liang, C., Ng, B., Punia, S., Xie, C., & Dietschy, J. M. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1149 · Cited by 118
Long-Lasting Cholinergic Modulation Underlies Rule Learning in Rats
Saar, D., Grossman, Y. R., & Barkai, E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01385.2001 · Cited by 118
Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats
Itoh, A., Akaike, T., Sokabe, M., Nitta, A., Iida, R., Olariu, A., Yamada, K., & Nabeshima, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00601-9 · Cited by 122
Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90140-4 · Cited by 118
Wallace, W., Ahlers, S. T., Gotlib, J. R., Bragin, V., Sugar, J., Gluck, R., SHEA, P. A., Davis, K. L., & Haroutunian, V. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8712 · Cited by 118
Koh, S., Chang, P., Collier, T. J., & Loy, R. (1989) · Brain Research · doi:10.1016/0006-8993(89)91125-6 · Cited by 118
Lin, S., Brown, R. E., Shuler, M. G. H., Petersen, C. C. H., & Kepecs, Á. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2590-15.2015 · Cited by 115
Kordower, J. H., Gash, D. M., Bothwell, M. A., Hersh, L. B., & Mufson, E. J. (1989) · Neurobiology of Aging · doi:10.1016/s0197-4580(89)80013-2 · Cited by 117
Melander, T., & Staines, W. A. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90222-3 · Cited by 117
Cho, H.-H., Cargnin, F., Kim, Y., Lee, B., Kwon, R.-J., Nam, H., Shen, R., Barnes, A. P., Lee, J. W., Lee, S., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004280 · Cited by 116
Extrinsic afferent systems to the dentate gyrus
Léránth, C., & Hajszán, T. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63004-0 · Cited by 120
Kordower, J. H., Charles, V., Bayer, R. A., Bartus, R. T., Putney, S. D., Walus, L. R., & Friden, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9077 · Cited by 116
Cooper, J. D., Lindholm, D., & Sofroniew, M. V. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90462-6 · Cited by 116
Martı́nez-Serrano, A., Fischer, W., Söderström, S., Ebendal, T., & Björklund, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6355 · Cited by 116
Pharmacological alleviation of cholinergic lesion induced memory deficits in rats
Haroutunian, V. H., Kanof, P. D., & Davis, K. L. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90531-4 · Cited by 116
Salamone, J. D., Beart, P. M., Alpert, J. E., & Iversen, S. D. (1984) · Behavioural Brain Research · doi:10.1016/0166-4328(84)90030-5 · Cited by 116
Amyloid-β oligomers in cellular models of Alzheimer’s disease
Fontana, I. C., Zimmer, A. R., Rocha, A. S., Gosmann, G., Souza, D. O., Lourenco, M. V., Ferreira, S. T., & Zimmer, E. R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15030 · Cited by 115
Park, D., Lee, H. J., Joo, S. S., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.040 · Cited by 115
Metadata
- Authors
- Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Neuropathology Laboratory, Departments of Pathology and Neurology, Baltimore, Maryland 21205
- Departments of Pharmacology and Experimental Therapy, Psychiatry, and Neuroscience, Baltimore, Maryland 21205
- ORCID
- DeLong, Mahlon R.
- Venue
- Science
- Published
- 1982-03-05
- Volume
- 215
- Issue
- 4537
- Pages
- 1237-1239
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2093374391
- Semantic Scholar
- e0380e88fdffd5a546eb76a1d2eb7d05db143f94
- Cited by
- 3,627
- References
- 44
- Citations by year
- 2026: 52 · 2025: 42 · 2024: 53 · 2023: 67 · 2022: 62 · 2021: 91 · 2020: 95 · 2019: 66 · 2018: 63 · 2017: 66 · 2016: 82 · 2015: 65 · 2014: 73 · 2013: 63 · 2012: 56
- FWCI
- 110.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, senile dementia, nucleus basalis of Meynert, basal forebrain, cholinergic neurons, neuronal loss, cholinergic deficit, cerebral cortex, presynaptic markers, subcortical lesions
- MeSH terms
- Acetylcholine, Alzheimer Disease, Basal Ganglia, Dementia, Humans, Neural Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review